109 related articles for article (PubMed ID: 35044455)
1. F-box protein 17 promotes glioma progression by regulating glycolysis pathway.
Deng C; Li H; Li Q
Biosci Biotechnol Biochem; 2022 Mar; 86(4):455-463. PubMed ID: 35044455
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FBXO17 Promotes the Proliferation, Migration and Invasion of Glioma Cells Through the Akt/GSK-3β/Snail Pathway.
Wang N; Song Q; Yu H; Bao G
Cell Transplant; 2021; 30():9636897211007395. PubMed ID: 33853342
[TBL] [Abstract][Full Text] [Related]
3. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of FBXO17 gene expression in high-grade glioma.
Du D; Yuan J; Ma W; Ning J; Weinstein JN; Yuan X; Fuller GN; Liu Y
BMC Cancer; 2018 Jul; 18(1):773. PubMed ID: 30064493
[TBL] [Abstract][Full Text] [Related]
5. ANXA2P2/miR-9/LDHA axis regulates Warburg effect and affects glioblastoma proliferation and apoptosis.
Du P; Liao Y; Zhao H; Zhang J; Muyiti ; Keremu ; Mu K
Cell Signal; 2020 Oct; 74():109718. PubMed ID: 32707073
[TBL] [Abstract][Full Text] [Related]
6. FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.
Suber TL; Nikolli I; O'Brien ME; Londino J; Zhao J; Chen K; Mallampalli RK; Zhao Y
Respir Res; 2018 Oct; 19(1):206. PubMed ID: 30359271
[TBL] [Abstract][Full Text] [Related]
7. NOX4-derived ROS Regulates Aerobic Glycolysis of Breast Cancer through YAP Pathway.
Zhang Z; Luan Q; Hao W; Cui Y; Li Y; Li X
J Cancer; 2023; 14(13):2562-2573. PubMed ID: 37670970
[No Abstract] [Full Text] [Related]
8. FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells.
Zheng ZM; Wang YY; Chen M; Yang HL; Lai ZZ; Li MQ; Shao J
Int J Med Sci; 2022; 19(9):1430-1441. PubMed ID: 36035375
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma.
Shi J; Zhang Y; Qin B; Wang Y; Zhu X
J Exp Clin Cancer Res; 2019 Sep; 38(1):395. PubMed ID: 31492194
[TBL] [Abstract][Full Text] [Related]
10. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
Guo H; Nan Y; Zhen Y; Zhang Y; Guo L; Yu K; Huang Q; Zhong Y
Tumour Biol; 2016 Oct; 37(10):13751-13761. PubMed ID: 27476171
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ZFAS1/miR-1271-5p/HK2 Promotes Glioma Development Through Regulating Proliferation, Migration, Invasion and Apoptosis.
Zhang B; Chen J; Cui M; Jiang Y
Neurochem Res; 2020 Dec; 45(12):2828-2839. PubMed ID: 32964288
[TBL] [Abstract][Full Text] [Related]
13. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
Li R; Li P; Wang J; Liu J
Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
[TBL] [Abstract][Full Text] [Related]
14. miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.
Hu S; Jiang Q; Luo D; Zhao L; Fu X; Chen Y; Song X; Li L; Zhao H; He Y; Peng B
Oncotarget; 2016 Jul; 7(30):48423-48431. PubMed ID: 27374173
[TBL] [Abstract][Full Text] [Related]
15. Lin28A promotes IRF6-regulated aerobic glycolysis in glioma cells by stabilizing SNHG14.
Lu J; Liu X; Zheng J; Song J; Liu Y; Ruan X; Shen S; Shao L; Yang C; Wang D; Cai H; Cao S; Xue Y
Cell Death Dis; 2020 Jun; 11(6):447. PubMed ID: 32527996
[TBL] [Abstract][Full Text] [Related]
16. Silencing long noncoding RNA LINC01138 inhibits aerobic glycolysis to reduce glioma cell proliferation by regulating the microRNA‑375/SP1 axis.
Xu C; Yin H; Jiang X; Sun C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643249
[TBL] [Abstract][Full Text] [Related]
17. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
18. KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K/AKT/mTOR pathway.
Wang K; Li J; Zhou B
Metab Brain Dis; 2022 Feb; 37(2):489-499. PubMed ID: 34792707
[TBL] [Abstract][Full Text] [Related]
19. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
20. A Novel Function of F-Box Protein FBXO17 in Negative Regulation of Type I IFN Signaling by Recruiting PP2A for IFN Regulatory Factor 3 Deactivation.
Peng D; Wang Z; Huang A; Zhao Y; Qin FX
J Immunol; 2017 Jan; 198(2):808-819. PubMed ID: 27956528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
